Keyphrases
Doxycycline
100%
Acute Exacerbation of COPD (AECOPD)
100%
Prednisolone
44%
External Validation
33%
Cost-effectiveness Analysis
33%
Asthma
33%
Prediction Model
33%
Randomized Controlled Trial
33%
Randomized Placebo-controlled Trial
33%
Performance Prediction
25%
Severe Exacerbations
25%
Antibiotics
24%
Severe COPD
24%
Placebo
24%
Placebo Groups
22%
Outpatient Setting
20%
Antibiotic Prescription
16%
American Thoracic Society
16%
Population Mean
16%
Sputum
16%
European Respiratory Society
16%
Netherlands
16%
Quality-adjusted Life Years
16%
Clinical Characteristics
16%
Secondary Care
16%
Confidence Interval
16%
Healthcare Utilization
13%
Chronic Obstructive Pulmonary Disease
12%
Severe Chronic Obstructive Pulmonary Disease
11%
Sensitivity Analysis
11%
Exclusion Criteria
11%
Generalizable Model
8%
Model Calibration
8%
Multivariable Model
8%
Adult Asthma
8%
Validation Population
8%
Primary Care Population
8%
C-statistic
8%
Predictive Properties
8%
Variable Population
8%
Asthma Exacerbation
8%
Distinct Population Segment
8%
Area under the Receiver Operating Characteristic Curve
8%
PubMed
8%
Spirometry
8%
Adult Patients
8%
Future Risk
8%
Embase
8%
Predictive Models
8%
Global Initiatives
7%
Medicine and Dentistry
Doxycycline
66%
Outpatient
66%
Chronic Obstructive Pulmonary Disease
66%
Asthma
33%
Systematic Review
33%
Placebo
33%
Secondary Care
33%
Primary Health Care
20%
Sputum
16%
Critical Appraisal
16%
Spirometry
16%
Asthma Exacerbation
16%
Patient with Asthma
16%
Health Care Utilization
16%
Antibiotics
14%
Adverse Event
7%
